The business of biotech

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

The business of biotech

Survival and success for biotech companies across the US and worldwide is a tenuous and arduous endeavor in today's economy. Robin Silva offers some tips on how to ride the wave successfully

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login
more from across site and SHARED ros bottom lb

More from across our site

The European IP team from Simmons & Simmons discusses the current approaches to IP enforcement against look-a-like or copycat products
Ten firms have each received more than 11 nominations, while more than 20 in-house counsel are up for awards
Yanfeng Xiong discusses 6am wake ups, honing his basketball skills, and how he prioritises tasks
Saina Shamilov explains how she convinced the Federal Circuit to upend the US ITC’s domestic industry analysis
Christopher Kinkade and Naira Simmons reveal the distributed firm’s hiring hopes for 2025, a little more than a year after it was founded
A CJEU copyright decision on employees' rights and an update on an IP feud concerning foreign rights over 'Superman' were also among the top talking points
Counsel explain how firms advising PTAB petitioners may react to the USPTO’s decision to ditch Fintiv guidance
The recruits include another former Stobbs lawyer, as well as a chief technology officer and chief financial officer
Jeffrey Saltman, who is anticipating a continued ‘ramping up’ of 5G patent litigation, has joined Cole Schotz
We look ahead to next month’s EMEA Awards, discussing the recently published shortlists, our research methodology and what makes the Awards special
Gift this article